Systems and methods for culturing epithelial cells

Patent metadata

Field	Value
Publication number	US-10801015-B2
Application number	US-201414772210-A
Country	US
Kind code	B2
Filing date	Mar 14, 2014
Priority date	Mar 15, 2013
Publication date	Oct 13, 2020
Grant date	Oct 13, 2020

Abstract

The present invention features assays for co-culturing primary cells while maintaining key biological activities specific to the primary cells. The invention is based, at least in part, on the discovery that compositions and methods for primary cells in a high-throughput co-culture platform, image analysis for distinguishing cells in co-cultures and assays that are suitable for screening of agents in epithelial cells, such as hepatocytes.

First claim

What is claimed is:

1. A co-culture for high throughput analysis of primary hepatocytes, comprising:
a layer of feeder cells disposed without aggregation in a well of a multi-well plate comprising at least 96 wells;
a layer of primary hepatocytes overlaid on the feeder cells wherein the hepatocytes are not contact inhibited and are at a density that allows for expansion of the hepatocytes in the co-culture for at least 7 days prior to a high throughput analysis; wherein the bottom surface of the well in the multi-well plate is coated with a cell adhesion substrate selected from the group consisting of collagen, fibronectin, vitronectin, laminin, entactin, Arg-Gly-Asp (RGD) peptide, Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide, glycosaminoglycans (GAGS), hyaluronic acid (HA), integrins, intercellular adhesion molecules (ICAMs), selectins, cadherin, cell-surface protein-specific antibodies, and a combination thereof; and wherein the feeder cells are disposed in a single confluent layer on the cell adhesion substrate; and
culture medium in the well of the multi-well plate in an amount sufficient to support hepatocyte expansion and maintain at least one biological activity of the hepatocytes for assessment in the high throughput analysis.

2. The co-culture of claim 1 , wherein the multi-well plate comprises at least 384 wells.

3. The co-culture of claim 1 , wherein the hepatocytes and feeder cells are plated at a ratio of 1:4.

4. The co-culture of claim 1 , wherein the hepatocyte biological activity is selected from the group consisting of albumin secretion, liver-specific protein synthesis, bile production, detoxification of compounds, energy metabolism, and cholesterol metabolism.

5. The co-culture of claim 1 , wherein the feeder cells and hepatocytes are of different species.

6. The co-culture of claim 1 , wherein the feeder cells comprise one or more types of non-parenchymal cells.

7. The co-culture of claim 6 , wherein the non-parenchymal cells are selected from the group consisting of fibroblast or fibroblast-derived cells and hepatic non-parenchymal cells.

8. The co-culture of claim 7 , wherein the hepatic non-parenchymal cells are selected from the group consisting of Kupffer cells, Ito cells, endothelial cells, stellate cells, cholangiocytes and hepatic natural killer cells.

9. The co-culture of claim 1 , wherein the feeder cells express a protein selected from the group consisting of Delta-like homolog 1; C-fos-induced growth factor; Ceruloplasmin; Decorin; Interferon regulatory factor 1; 204 interferon-activatable protein; Splicing factor, arginine/serine-rich 3; JKTBP; Autoantigen La; High mobility group box 1; Esk kinase; dihydrofolate reductase gene: 3′ end; Pm1 protein and Rac GTPase-activating protein 1.

10. The co-culture of claim 1 , wherein the culture medium comprises hydrocortisone.

11. The co-culture of claim 1 , wherein the primary hepatocytes are overlaid on the feeder cells in an amount of about 5×10 3 cells/well or fewer in a multi-well plate having 384 wells.

12. The co-culture of claim 1 , wherein the hepatocytes are stable in the co-culture for at least 9 days without hepatocyte crowding.

13. A co-culture platform for high throughput analysis of primary hepatocytes, comprising:
a layer of feeder cells disposed without aggregation in a well of a multi-well plate comprising at least 96 wells;
a layer of primary hepatocytes overlaid on the feeder cells wherein the hepatocytes are not contact inhibited and are at a density that allows for expansion of the hepatocytes in the co-culture for at least 7 days prior to a high throughput analysis; wherein the bottom surface of the well in the multi-well plate is coated with a cell adhesion substrate selected from the group consisting of collagen, fibronectin, vitronectin, laminin, entactin, Arg-Gly-Asp (RGD) peptide, Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide, glycosaminoglycans (GAGS), hyaluronic acid (HA), integrins, intercellular adhesion molecules (ICAMs), selectins, cadherin, cell-surface protein-specific antibodies, and a combination thereof; wherein the feeder cells express a protein selected from the group consisting of Delta-like homolog 1, C-fos-induced growth factor, Ceruloplasmin, Decorin, Interferon regulatory factor 1, 204 interferon-activatable protein, Splicing factor, arginine/serine-rich 3, JKTBP, Autoantigen La, High mobility group box 1, Esk kinase, dihydrofolate reductase gene: 3′ end, Pml protein and Rac GTPase-activating protein 1; and wherein the feeder cells are disposed in a single confluent layer on the cell adhesion substrate; and
culture medium in the well of the multi-well plate in an amount sufficient to support hepatocyte expansion and maintain at least one biological activity of the hepatocytes for assessment in the high throughput analysis.

14. The co-culture of claim 13 , wherein the hepatocyte biological activity is selected from the group consisting of albumin secretion, liver-specific protein synthesis, bile production, detoxification of compounds, energy metabolism, and cholesterol metabolism.

15. The co-culture of claim 13 , wherein the feeder cells and hepatocytes are of different species.

16. The co-culture of claim 13 , wherein the feeder cells comprise one or more types of non-parenchymal cells.

17. The co-culture of claim 16 , wherein the non-parenchymal cells are selected from the group consisting of fibroblast or fibroblast-derived cells and hepatic non-parenchymal cells.

18. The co-culture of claim 17 , wherein the hepatic non-parenchymal cells are selected from the group consisting of Kupffer cells, Ito cells, endothelial cells, stellate cells, cholangiocytes and hepatic natural killer cells.

19. The co-culture of claim 13 , wherein the primary hepatocytes are overlaid on the feeder cells in an amount of about 5×10 3 cells/well or fewer in a multi-well plate having 384 wells.

20. The co-culture of claim 13 , wherein the hepatocytes are overlaid onto the feeder cells at a ratio of 1:4 or less.

21. The co-culture of claim 13 , wherein the multi-well plate comprises at least 384 wells.

22. The co-culture of claim 13 , wherein the hepatocytes are stable in the co-culture for at least 9 days without hepatocyte crowding.

Assignees

• Broad Inst Inc
• Massachusetts Inst Technology

Inventors

• Bhatia Sangeeta
• Shan Jing
• Van Dyk Anne Carpenter
• Logan David
• Ross Nathan

Classifications

• C12N5/067 Primary

  Hepatocytes · CPC title

• C12N2531/00

  Microcarriers · CPC title

• C12N2502/1323

  Adult fibroblasts · CPC title

• C12Q1/04

  Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title